Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE Subjective improvement in OSA symptoms was reported by all patients and objective PSG improvement was reported for 71% of those evaluated. 30639150

2019
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE In the traditional PSG-based OSA detection, people's sleep may be disturbed, meanwhile the electrode slices are easily to fall off. 31499731

2019
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE A total of 90 patients were enrolled into the study, 50 subjects were divided into OSA groups and 40 in healthy control according to PSG examination. 29843666

2018
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE Clinical and PSG factors were examined as predictors of OSA. 29880147

2018
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE A second PSG study performed 2 months postoperatively to confirm OSA resolution, and those with residual OSA were excluded. 30368376

2018
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE Surprisingly, RSWA values in PSG with melatonin were high, probably because of the still untreated OSAS. 28545360

2017
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE The review included observational studies in the English language with a clearly established aim to assess the relationship between OSAS and SB using full-night PSG. 27977045

2017
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE Sleep specialists should use the SBQ to conduct patient interviews for the early diagnosis of OSA in clinical settings, particularly in resource-poor countries and sleep clinics where PSG is unavailable. 27919588

2017
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE Within this population, L-PSG underestimates obstructive sleep apnea and central sleep apnea compared to H-PSG. 28934528

2017
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 GeneticVariation BEFREE The study group (PSG-confirmed OSAS) included 62 individuals, aged 51.7±10.3 years. 28501722

2017
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive 		0.100 Biomarker BEFREE Preoperative and postoperative (6 months) physical examination, PSG, bone age (BA) and osteocalcin (OC) evaluation were performed on the selected OSA children (n=92) and the healthy children (n=87). 27917446

2017